<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Oncology Drug Products Used With Certain In Vitro Diagnostic Tests: Pilot Program; Guidance for Industry, Clinical Laboratories, and Food and Drug Administration Staff; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Oncology Drug Products Used With Certain In Vitro Diagnostic Tests: Pilot Program; Guidance for Industry, Clinical Laboratories, and Food and Drug Administration Staff; Availability</h1>
    <p class="timestamp">Published: 2023-06-21 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry, clinical laboratories, and FDA staff entitled ``Oncology Drug Products Used with Certain In Vitro Diagnostic Tests: Pilot Program.'' FDA is issuing this guidance to announce and describe FDA's voluntary pilot program for certain oncology drug products regulated by FDA's Center for Drug Evaluation and Research (CDER) used with certain in vitro diagnostic tests. FDA intends to pilot a ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-13134</p>
    <p><strong>Publication Date:</strong> 2023-06-21</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/06/21/2023-13134/oncology-drug-products-used-with-certain-in-vitro-diagnostic-tests-pilot-program-guidance-for">https://www.federalregister.gov/documents/2023/06/21/2023-13134/oncology-drug-products-used-with-certain-in-vitro-diagnostic-tests-pilot-program-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-13134</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
